tiprankstipranks
Trending News
More News >
Antengene Corporation Limited (DE:722)
FRANKFURT:722

Compare Antengene Corporation Limited (722) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Antengene Corporation Limited
€0.53
€284.50M
-5.39
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$14.16
HK$15.03B
-22.61
53.25%
2 Buy
0 Hold
0 Sell
Moderate Buy
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$4.04B
-16.66
155.12%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.24B
-2.54
-36.59%
SinoMab Bioscience Ltd.
HK$1.39
HK$2.32B
-10.54
38.52%
Immunotech Biopharm Ltd
HK$2.68
HK$1.57B
-2.55
-37.64%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:722
Antengene Corporation Limited
0.43
-0.03
-6.52%
HK:1672
Ascletis Pharma, Inc.
14.16
4.96
53.91%
HK:1875
TOT BIOPHARM International Co. Ltd.
5.23
3.18
155.12%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
4.68
-2.70
-36.59%
HK:3681
SinoMab Bioscience Ltd.
1.69
0.52
44.44%
HK:6978
Immunotech Biopharm Ltd
2.54
-1.18
-31.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts